Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study

This study used data from the National Cancer Database (NCDB), a hospital-based, de-identified oncology registry jointly sponsored by the American College of Surgeons and the Commission on Cancer. The NCDB data are available to qualified investigators through an application process and Institutional Review Board approval; individual patient-level data are not publicly accessible. Table S1. Baseline characteristics of patients with classical Hodgkin lymphoma stratified by era of diagnosis. Table S2. Five-year survival rates by era across different patient subgroups. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.